Unlocking Epigenetic Secrets from the Uterus: Therapeutic Options for Advanced and Recurrent Endometrial Cancer– Twitter Chat #1 Evaluation (ID: i778-4) Survey

Once you complete and submit the evaluation, please be sure to select your credit amount and click “Continue to Certificates” to claim credit.

Question Title

* 1. Please select the option that best describes your practice setting.

Gynecologic Oncology

Oncology (other focus)

OB/GYN

Emergency Medicine Physician

Other Specialist

Internal Medicine

Family Practice

Other (please specify)

Question Title

* 2. Please select the option that best describes your practice setting:

Academic medical center

Community hospital or medical center

VA, DOD, or other government

Managed care

Research

Pharmaceutical industry

Question Title

* 3. How many years have you been in practice?

1-10

11-20

>20

Not in practice

Question Title

* 4. How many patients with EC do you manage per week?

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 5. After participating in this activity, how confident are you in the management of patients with EC in your practice?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 6. How confident are you in recognizing irAEs in your EC patients being treated with ICIs?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 7. Please rate your level of agreement with the following statement: Supportive and/or palliative care should be offered as early as possible following diagnosis of EC.

Agree completely

Somewhat agree

Neutral

Somewhat disagree

Disagree completely

Question Title

* 8. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Improved understanding of how to monitor for and recognize irAEs

Increased ability to manage immunotherapy toxicity based on existing guidelines

Be better able to implement patient-centric care designed to preserve or restore patient quality of life

Other (explain)

Question Title

* 9. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason

Question Title

* 10. What barriers do you see to making changes in your practice? Please select all that apply.

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other

Question Title

* 11. After participating in today’s activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Develop a strategy for identifying and addressing AEs caused by immunotherapy and/or combination treatments	Develop a strategy for identifying and addressing AEs caused by immunotherapy and/or combination treatments Strongly agree	Develop a strategy for identifying and addressing AEs caused by immunotherapy and/or combination treatments Agree	Develop a strategy for identifying and addressing AEs caused by immunotherapy and/or combination treatments Neutral	Develop a strategy for identifying and addressing AEs caused by immunotherapy and/or combination treatments Disagree	Develop a strategy for identifying and addressing AEs caused by immunotherapy and/or combination treatments Strongly disagree
Incorporate a patient-centric treatment approach that considers each woman’s well-being and QOL	Incorporate a patient-centric treatment approach that considers each woman’s well-being and QOL Strongly agree	Incorporate a patient-centric treatment approach that considers each woman’s well-being and QOL Agree	Incorporate a patient-centric treatment approach that considers each woman’s well-being and QOL Neutral	Incorporate a patient-centric treatment approach that considers each woman’s well-being and QOL Disagree	Incorporate a patient-centric treatment approach that considers each woman’s well-being and QOL Strongly disagree

Question Title

* 12. Please rate your level of agreement by checking the appropriate rating.

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Faculty for this activity was effective	Faculty for this activity was effective Strongly agree	Faculty for this activity was effective Agree	Faculty for this activity was effective Neutral	Faculty for this activity was effective Disagree	Faculty for this activity was effective Strongly disagree
Content was scientifically rigorous and evidence based	Content was scientifically rigorous and evidence based Strongly agree	Content was scientifically rigorous and evidence based Agree	Content was scientifically rigorous and evidence based Neutral	Content was scientifically rigorous and evidence based Disagree	Content was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Unlocking Epigenetic Secrets from the Uterus: Therapeutic Options for Advanced and Recurrent Endometrial Cancer– Twitter Chat #1 Evaluation (ID: i778-4)

Question Title

* 1. Please select the option that best describes your practice setting.

Question Title

* 2. Please select the option that best describes your practice setting:

Question Title

* 3. How many years have you been in practice?

Question Title

* 4. How many patients with EC do you manage per week?

Question Title

* 5. After participating in this activity, how confident are you in the management of patients with EC in your practice?

Question Title

* 6. How confident are you in recognizing irAEs in your EC patients being treated with ICIs?

Question Title

* 7. Please rate your level of agreement with the following statement: Supportive and/or palliative care should be offered as early as possible following diagnosis of EC.

Question Title

* 8. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 9. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 10. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 11. After participating in today’s activity, I am now better able to:

Question Title

* 12. Please rate your level of agreement by checking the appropriate rating.

Question Title

* 13. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 14. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 15. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities: